Acadia Pharmaceuticals Inc. · NASDAQ:ACAD
Baker Brothers Life Sciences LP received 18,622 Acadia Pharmaceuticals Inc. shares as an award (Form 4)
Traded May 29, 2026 · Filed Jun 2, 2026
On May 29, 2026, Baker Brothers Life Sciences LP (Director, 10% owner) received 18,622 Acadia Pharmaceuticals Inc. shares as an award, leaving 3,677,357 shares. Filed Jun 2, 2026 (Form 4).
- Awarded
- 18,622 shares
- Holding after
- 3,677,357 shares (held indirectly)
- Trading plan
- No
- Role
- Director, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 29, 2026 | Common Stock | Award | 18,622 | 3,677,357 | Indirect |
Source
Related
- Acadia Pharmaceuticals Inc.
- Baker Brothers Life Sciences LP
- Acadia Pharmaceuticals Inc. shareholders
- Form 4 · Schneyer Mark C. · Aug 7, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Thompson Elizabeth H.Z. · Jul 31, 2026
- Form 4 · Kihara James · Jun 29, 2026
- Form 4 · Harrigan Edmund · Jun 1, 2026